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ABSTRACT
Background: Impaired liver function tests and co-infection with hepatitis viruses in AIDS
patients are common in western countries.
Objective: To assess liver function and prevalence of co-infection with hepatitis B and
hepatitis C viruses in AIDS patients at Chris Hani Baragwanath Hospital.
Design: A prospective study.
Setting: Chris Hani Baragwanath Hospital, Johannesburg, South Africa.
Patients: One hundred consecutive patients with AIDS admitted to Chris Hani Baragwanath
Hospital.
Results: There were 52 males and 48 females aged 16 to 54 years (mean + SD: 34.6 +
7.5 years). The results of laboratory test were as follows: LFTs: bilirubin 11.8 (+15.6) µmol/
l; AST: 79.6 (±116.6) iu/L; alkaline phosphatase: 204.3 (±237.4) iµ/L; albumin: 23.9 (±6.2)
g/l; CD4+ Iymphocytes: 141.5 (±168.6) µl; CD8+: 666.9 (±618.3) µl; HBV - HbsAg: 6 (6%);
HbsAg + eAg: 3 (3%); previous disease (Anti HBs and/or anti HBc): 35%, HCV: 1(1%).
Conclusion: Liver function tests were impaired in the majority of patients with AIDS (93%)
in our setting. Evidence of previous and present HBV infection was present in 41%. This
is different from what is observed in western countries (90-95%). The results also suggest
that patients here acquired HBV infection while still immuno competent. HCV infection
was rare.
INTRODUCTION
Both HIV and HBV infections share common
modes of transmission, predominantly blood exposure
and high risk sexual activity. From studies conducted
in western countries, 90-95% of patients with AIDS had
serological evidence of present or past HBV infection(
l,2). Hepatitis C virus infection is also transmitted by
parenteral routes and co-infection with HIV among
patients with history of intravenous drug use (IVDU)
or blood transfusion are common(3,4). However, it is
less clear whether HCV, like HIV is sexually transmitted.
Wright et al(4) study from San Francisco, California
found 11.7% prevalence of HCV/HIV co-infection
which could not be accounted for by IVDU or blood
transfusion compared to one per cent in the HIV
negative patients.
Previous studies in western countries indicate that
up to 90% of patients with AIDS had abnormalities
of their liver enzymes at presentation(5-l0). Aetiological
factors were multiple ranging from infections, neoplasms
to medications(l0). Neither type of enzyme abnormality
could predict a particular infection, neoplasm or drug
use(8,11).
Between 12 and 35% of South Africans are
infected with HIV and between 40 and 60% of
admissions in medical wards in State hospitals have
HIV-infection(12). From available statistics here, it has
been observed that 40% of our HIV patients have
impaired liver transaminases. Reports from the National
Institute of Virology of South Africa, also show that
eight to fifteen per cent of South African blacks are
HBV carriers (HbsAg positive) and three to five per
cent have antibodies to HCV( l2).
Against this background, we set out to determine
the prevalence of HBV and HCV serological markers
as well as the evaluation of liver function and T cell
Iymphocyte subsets (CD4+/CD8+) in AIDS patients
admitted to CHB Hospital.
MATERIALS AND METHODS
One hundred consecutive patients with serologic evidence
of HlV-infection who fulfilled the 1993 revised classification
system for HlV-infection and the expanded AIDS surveillance
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case definition for adolescents and adults( 13) criteria
for AIDS, admitted to the medical wards in CHB
Hospital in May 1999. Informed consent was obtained
from the patients. The following tests were carried out:
(i) liver function tests, namely, alkaline aminotransferase
(ALT), aspartate aminotransferase (AST), alkaline
phosphatase (Alk Phosph), gamma glutamyl transferase
(GGT), bilirubin levels, serum albumin and total serum
proteins, using standard routine spectrophotometric
methodology; (ii) T Iymphocyte subsets CD4+ and
CD8+ using flow cytometry; (iii) hepatitis B virus
markers: hepatitis B surface antigen (HbsAg), hepatitis
e antigen (HBeAg), hepatitis B surface antibody (Anti
HBs), hepatitis B core antibody(AntiHBc)using Abbott's
diagnostic kits and; (iv) hepatitis C virus antibody (Anti
HCV) using standard third generation ELISA kits.
RESULTS
Fifty two males and 48 females were studied. The
age range was 16 to 54 years (Mean ± SD; 34.6 ±
7.5 years). The liver function tests, serum proteins and
T cell subset counts are as shown in Table 1. Ninety
seven per cent of patients had elevated globulin and/
or reduced serum albumin, 70% had elevated AST and/
or ALT and 78% had elevated GGT. CD4+ counts were
generally low and CD8+ lymphocyte counts were
within or above the normal levels in the majority of
patients. The liver enzymes suggest there was a
preponderance towards hepatobiliary obstruction relative
to hepatocyte injury. Table 2 shows the prevalence of
HBV and HCV serological markers in our study
population. The overall prevalence of present and past
HBV viral infection was 41%, with six patients carriers
of HBsAg and three positive for HBeAg. Hepatitis C
virus antibodies were rare (one per cent). None of the
patients had been vaccinated against HBV.
DISCUSSION
HIV, HBV and HCV share common modes of
transmission, namely, blood exposure for all high risk
sexual behaviour for HIV and HBV. The role of high
risk sexual behaviour in HCV transmission is
controversial. Our results show that HBV/HIV co-
infection (41 %) is not as common as the western series
of 90-95%(1,4,11 ) and HCV/HIV co-infection of one
per cent much lower than the 11.7% found by Wright
et al(4) in patients without a history of intravenous drug
use. Fifteen per cent of those who had HBV-infection
developed a HBsAg chronic carrier state and 50% of
those with HBsAg had HBeAg. This compares well
with ten per cent HBsAg carrier rate and 66% of
HBeAg positivity in those with HBsAg found by Rustgi
et al(2). None of the patients with HBsAg had elevated
bilirubin, two had slight elevation of AST, one ALT
Table 1
Liver function tests, globulins and T cell subsets
Liver function tests T cell
Bilirubin Serum enzymes Serum proteins Subsets
Total Direct Indirect AST ALT ALK Phosp GGT Total ALB GLos CD4+ CD8+
µmoi/L µmol/L µmol/L lu.L iu.L lu/L Iu/L g/L g/L g/L mm3 mm3
Mean 11.8 5.99 5.8 79.6 44.6 204.3 105.5 78.7 23.9 55.1 141.6 666.9
SD 15.6 21.1 4.5 116.6 72.6 237.4 119.6 15.6 6.2 14.6 168.6 618.3
Normal values 5.1-17 1.7-5.1 3.4-12 0-35 0-35 3.0-120 7-40 55-80 32-52 20-35 500-2010 250-990
% with
abnormal results 14% 66% 36% 56% 78% 44% 86% 93%
Table 2
Hepatitis B virus and hepatitis C serological markers
Hepatitis B virus markers HCV
Serological HbsAg Anti HBs HBeAg Anti HBc Anti HCV
Markers
No 6 35 3 41 1
% of total 6 35 3 41 1
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and one, both ALT and AST were minimally elevated.
These findings also concur with those of Rustgi(2). The
serological results suggest that most of the patients who
developed HBV infection did so when they were still
immunocompetent. Patients with immunodeficiency
syndromes or those who are exogenously
immunosuppressed are at an increased risk of developing
the chronic HBsAg carrier state as shown among
patients on renal dialysis who develop an HBV carrier
rate of 60-90%(14). If these patients had developed
HBV after developing immunodeficiency, a higher
percentage might be expected to become chronic
HBsAg carriers. The percentage of patients who were
HBsAg carriers (six out of 41) is characteristic of the
percentage of young adults infected with this virus who
develop the chronic carrier state(15 - 16). During the
course of HIV infection, the liver and the biliary tract
often get affected with opportunistic infections,
neoplasms or effect of drug therapy used in
treatment(911). Ninety six per cent of our patients had
a reduced serum albumin and/or an elevated globulin
levels. At least one of the serum enzyme levels was
elevated in 88% of the cases: GGT in 78%, AST and/
or ALT in 70% and alkaline phosphatase in 56% of
the cases. These high enzyme levels were more frequent
than in previous studies(5-9). This could be due to the
fact that most of our patients were in more advanced
stages of their disease (CD4+ count 141.5 ± 158.6/
mm3). In the past, it was felt that in patients with AIDS
or even early stages of HIV, chronic viral hepatitis was
not likely to affect life expectancy or to cause a
significant number of complications. However, as our
ability to treat HIV infection improves, hepatitis viruses
may emerge as important pathogens in patients with
HIV infection. In conclusion, most of the patients
evaluated were in advanced stages of AIDS and had
impaired liver function tests. Evidence of past and
present HBV infection was present in 41% of the
patients. This is in contrast to the high levels observed
in western countries. However, the HBsAg carrier rate
in our study was similar to that observed in western
countries. The results suggest that AIDS patients in
Soweto and in western countries acquired HBV infection
while still immunocompetent. HCV infection was rare
being, one per cent compared with 11.7% found in the
USA. This suggests that in our group of patients sexual
transmission of HCV is not a major factor.
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